Inhibrx, inc. - Report of Organizational Actions Affecting Basis of Securities
On May 29, 2024, Inhibrx, inc. (the "company") distributed 92% of the issued and outstanding shares of the common stock in its subsidiary, Inhibrx biosciences, inc. (the "subsidiary") to company's common shareholders as of the distribution record date, May 17, 2024. The distribution was made on a pro rata basis, at a ratio of one share of the subsidiary's common stock for every four shares of the company's issued and outstanding common stock held on the distribution record date.
EuroAPI - Report of Organizational Actions Affecting Basis of Securities
on May 10, 2022, the organizational action was a distribution by Sanofi of 58% of the outstanding common shares (which were previously 100% owned by Sanofi) of Euroapi S.A. (“Euroapi”) to Sanofi common shareholders pro rata.